GlassScriptPhysician profile
Michael P Herman
NPI 1144487943
$5,461.67
in general payments reported to CMS, 2019-2025
32 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,626 · 2020: $771 · 2021: $572 · 2022: $555 · 2023: $436 · 2024: $338 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,408 · Travel and Lodging: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,407.82 |
| Travel and Lodging | $528.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,618.99 | 2019-2025 | Aquabeam Robotic System |
| Neotract INC. | $1,250.77 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $350.02 | 2021-2025 | Prolaris, Myrisk |
| Janssen Biotech, INC. | $297.21 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $248.67 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $219.47 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $183.19 | 2021-2024 | Urolift |
| Urogen Pharma, INC. | $177.62 | 2022-2025 | Jelmyto |
| Novartis Pharmaceuticals Corporation | $133.16 | 2025 | |
| Myovant Sciences INC. | $107.31 | 2021-2022 | |
| Pfizer INC. | $106.49 | 2019-2024 | |
| Civco Medical Instruments | $95.52 | 2024-2025 | |
| Tolmar Pharmaceuticals, INC. | $79.35 | 2019-2021 | |
| Antares Pharma, INC. | $75.16 | 2022-2024 | Xyosted |
| Abbvie INC. | $67.19 | 2020-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $60.41 | 2023-2025 | Pylarify |
| Ferring Pharmaceuticals INC. | $41.13 | 2019-2024 | Adstiladrin |
| Srs Medical Systems, INC. | $38.02 | 2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Laborie Medical Technologies Corp. | $34.98 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Axonics, INC. | $33.97 | 2023-2024 | Bulkamid |
| Hologic Sales and Service, LLC | $30.67 | 2024 | Localizer, Trident Specimen Radiography System |
| Cycle Pharmaceuticals INC | $28.58 | 2024 | Tiopronin |
| Boston Scientific Corporation | $26.43 | 2019 | |
| Urovant Sciences INC | $23.71 | 2022 | |
| Telix Pharmaceuticals | $22.73 | 2024 | Illuccix |
| Mimedx Group, INC. | $20.49 | 2024 | |
| Intercept Pharmaceuticals, INC. | $20.13 | 2020 | |
| Acerus Pharmaceuticals Corporation | $19.33 | 2022 | |
| Travere Therapeutics, INC. | $16.61 | 2019 | |
| Tersera Therapeutics LLC | $15.36 | 2019 | |
| Tolmar, INC. | $14.62 | 2023 | |
| Checkpoint Surgical, INC | $4.38 | 2025 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Herman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.